INTECH Investment Management’s Y-mAbs Therapeutics YMAB Stock Holding History

INTECH Investment Management’s Portfolio YMAB Stock Details YMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-21,674	Closed	-$97.8K	–	2530
2025 Q2	$97.8K	Sell	21,674 -5,021	-19%	-$22.6K	﹤0.01%	2300
2025 Q1	$118K	Buy	26,695 +4,519	+20%	+$26.2K	﹤0.01%	2271
2024 Q4	$174K	Buy	22,176 +12,027	+119%	+$146K	﹤0.01%	2076
2024 Q3	$133K	Buy	+10,149	New	+$129K	﹤0.01%	1831

Other funds holding YMAB

BIG

Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

INTECH Investment Management's YMAB Position: Q3 2025 in Review

INTECH Investment Management sold out of Y-mAbs Therapeutics (YMAB) in Q3 2025, closing a stake of 21,674 shares — an estimated $97.8K sold.

INTECH Investment Management first reported a position in YMAB in Q3 2024 and held it in 4 quarters. The position peaked at $174K in Q4 2024. 2 funds tracked by Wall St. Rank hold YMAB as of Q3 2025.

INTECH Investment Management reported no remaining Y-mAbs Therapeutics position as of Q3 2025 after selling out during the quarter.
INTECH Investment Management sold 21,674 Y-mAbs Therapeutics shares in Q3 2025, an estimated $97.8K.
INTECH Investment Management first reported a position in Y-mAbs Therapeutics in Q3 2024 and held it in 4 quarters.
INTECH Investment Management's Y-mAbs Therapeutics position peaked at $174K in Q4 2024.
2 funds tracked by Wall St. Rank held Y-mAbs Therapeutics as of Q3 2025.

Based on INTECH Investment Management's 13F filing for Q3 2025, filed 12 Nov 2025.